Documents & Downloads

Osteostatin

Osteoclastic bone resorption inhibitor

Osteostatin is a fragment of parathyroid hormone-related protein (PTHrP 107-111) that serves as an inhibitor of osteoclastic bone resorption. This compound has demonstrated the ability to promote bone repair in various animal models of bone defects and to prevent bone erosion associated with inflammatory arthritis. Osteostatin is applicable in research focused on inflammation and immunology, particularly in studies investigating its role in arthritis and bone health.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	138949-73-2
Applications	Osteoclastic bone resorption inhibitor
Formula	C₂₇H₄₁N₉O₈
Molecular Weight	619.67
Synonyms	PTHrP (107–111)
SMILES	C([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]([C@@H](C)O)N)=O)CCCNC(=N)N)=O)CO)=O)C)=O)C(O)=O)C=1C=2C(NC1)=CC=CC2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.